Home
About
Overview
Management Team
Board of Directors
Clinical Advisors
SYN-004 Phase 3 Steering Committee
Careers
Product Pipeline
Overview
SYN-004 (ribaxamase)
SYN-004 Phase 3 Steering Committee
SYN-010
News & Media
Overview
Press Releases
Events
In the News
Scientific Publications
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
Press Releases
Menu
Overview
Press Releases
Events
In the News
Scientific Publications
All News
2018
2017
2016
2015
2014
2013
2012
February 16, 2012
Adeona Becomes Synthetic Biologics, Inc.
« Previous
1...
13
14
15
16
17
18
19
20
21
22
